Literature DB >> 8188843

Magnesium sulfate treatment of preterm labor as a cause of abnormal neonatal bone mineralization.

M D Santi1, G W Henry, G L Douglas.   

Abstract

Twelve infants born to mothers who received i.v. magnesium sulfate for > 6 weeks for the cessation of preterm labor were evaluated radiographically shortly after birth. All infants were born at > 33 weeks gestational age. All twelve infants demonstrated consistent and unique radiographic abnormalities in the metaphyses of their long bones. The extent of abnormality was at least partially related to the length of magnesium sulfate exposure, and appeared to completely resolve within the first few months of life.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8188843     DOI: 10.1097/01241398-199403000-00022

Source DB:  PubMed          Journal:  J Pediatr Orthop        ISSN: 0271-6798            Impact factor:   2.324


  4 in total

1.  Neonatal bone abnormalities attributable to maternal administration of magnesium sulphate.

Authors:  Hirokazu Tsukahara; Ritsuyo Kobata; Satoshi Tamura; Mitsufumi Mayumi
Journal:  Pediatr Radiol       Date:  2004-06-18

Review 2.  Role of magnesium sulfate in seizure prevention in patients with eclampsia and pre-eclampsia.

Authors:  J Anthony; R B Johanson; L Duley
Journal:  Drug Saf       Date:  1996-09       Impact factor: 5.606

Review 3.  Overrepresentation of multiple birth pregnancies in young infants with four metabolic bone disorders: further evidence that fetal bone loading is a critical determinant of fetal and young infant bone strength.

Authors:  M Miller; T Ward; A Stolfi; D Ayoub
Journal:  Osteoporos Int       Date:  2014-04-03       Impact factor: 4.507

4.  Bone mineralization in newborns whose mothers received magnesium sulphate for tocolysis of premature labour.

Authors:  Shadi N Malaeb; Adriana I Rassi; Maurice C Haddad; Muhieddine A Seoud; Khalid A Yunis
Journal:  Pediatr Radiol       Date:  2004-02-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.